Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Votrient in VEGF-TKI refractory metastatic renal cell carcinoma
NCT01157091Phase 2Completed
- Sponsor
- City of Hope
- Start
- Dec 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in clear cell renal cell carcinoma (ccRCC), sponsored by City of Hope. Started Dec 2010; status: completed.
02
Drugs
pazopanib
03
Conditions
clear cell renal cell carcinoma (ccRCC)
Beyond the preview
Go deeper on NCT01157091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01157091.